Basic information Uses Safety Supplier Related

5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID

Basic information Uses Safety Supplier Related

5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID Basic information

Product Name:
5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID
Synonyms:
  • 5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID
  • 1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-bromo-
  • 5-Bromo-7-azaindole-3-carboxylic acid
  • 5-Bromo-7-azaindole-3-car...
  • 3-b]pyridine-3-carboxylic acid
  • 5-BroMo-7-azaindole-3-carboxylic
  • 5-Bromopyrrolo[2,3-b]pyridine-3-carboxylic Acid
  • 5-bromo-1H-pyrrolo[5,4-b]pyridine-3-carboxylic acid
CAS:
849068-61-7
MF:
C8H5BrN2O2
MW:
241.04
Product Categories:
  • CHIRAL CHEMICALS
Mol File:
849068-61-7.mol
More
Less

5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID Chemical Properties

Density 
1.946±0.06 g/cm3(Predicted)
storage temp. 
2-8°C(protect from light)
form 
solid
pka
13.34±0.40(Predicted)
Appearance
White to off-white Solid
More
Less

Safety Information

Hazard Codes 
Xi,Xn
Risk Statements 
22-36
Safety Statements 
26-24/25
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
29339900
More
Less

5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID Usage And Synthesis

Uses

5-Bromo-1H-pyrrolo[2,3-B]pyridine-3-carboxylic acid is an important raw material in organic synthesis. Its derivative, pyrrolopyridine-2-carboxamide, is a glycogen phosphorylase inhibitor used to prevent or treat diabetes, hypertension, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, atherosclerosis, or tissue ischemia, and can also be used as a cardioprotective agent.

Synthesis

76-02-8

183208-35-7

849068-61-7

The general procedure for the synthesis of 5-bromo-1H-pyrrolo[2,3-B]pyridine-3-carboxylic acid using 5-bromo-7-azaindole and trichloroacetyl chloride as starting materials was as follows: 5-bromo-7-azaindole (10.00 g, 50.75 mmol) was dissolved in dichloromethane (200 mL), followed by the addition of aluminum chloride (34.00 g, 254.99 mmol). stirred for 10 minutes at room temperature. Next, trichloroacetyl chloride (8.6 mL, 77 mmol) was added slowly and the reaction continued to be stirred at room temperature overnight. After completion of the reaction, the reaction mixture was slowly poured into ice water and filtered to collect the white solid. The filtrate was extracted with ethyl acetate (200 mL x 3). The organic phases were combined and concentrated to give a white solid. The solid was dissolved in water (125 mL), triethylamine (50 mL) was added and stirred at room temperature for 24 hours. At the end of the reaction, the solvent was concentrated to remove the solvent, the pH was adjusted to 5-6 with 1.0 M dilute hydrochloric acid, the product was collected by filtration and dried at 50 °C to give the final 5-bromo-1H-pyrrolo[2,3-B]pyridine-3-carboxylic acid (8.20 g, off-white solid) in 67.0% yield.

References

[1] Journal of Medicinal Chemistry, 2017, vol. 60, # 5, p. 2052 - 2070
[2] Patent: CN106336413, 2017, A. Location in patent: Paragraph 0557; 0558; 0559

5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLIC ACIDSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
ITIC MEDCHEM(SUZHOU) CO.,LTD.
Tel
0512-68323967 18015559028
Email
sales@iticmedchem.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Shangchem Co., Ltd.
Tel
+86-21-68182121